Connected Care
Discover how the Libre Ecosystem of products and apps connect together to help you manage your diabetes better.
The Libre 3 Plus 15-day sensor delivers minute-by-minute glucose readings and is authorised to work with the mylife Loop AID system.
Speak to your healthcare professional for more information.
Discover more >
ADC 119545 v1.0
5-7 day delivery (Estimated standard delivery)
All payments are secure and encrypted
Your cart is empty
Do you want to shop our Products?
Explore our FreeStyle Libre 2 Sensor and add it to your Cart.
You will now receive glucose information in the LibreLinkUp app. You do not need to have the LibreLinkUp app running to receive notifications from your connections. You can connect with up to 20 LibreLink app users to see their glucose readings.
If you successfully installed LibreLinkUp and set up your account, but do not see a notification from the LibreLink user, make sure that your phone has an active Internet connection (Wi-Fi or mobile) and your phone settings allow you to receive notifications.
If you still do not see an invitation and you know that the invitation was sent, ask the LibreLink app user who invited you to send a new invitation to the email address that you used when installed LibreLinkUp.
Download the LibreLinkUp app§, connect it to your loved-one's LibreLink app , and you can keep up-to-date with their sugar levels, wherever they are.ǁ,Ѱ
With LibreLinkUp,§ family and caregivers get real-time accessII to their loved-one's glucose information and customisable alarms^ for peace of mind.1
Rely on proven alarm accuracy at every glucose level.2
When connected, parents and caregivers get real-time access to their glucose information and customisable alarms^, offering the freedom to be out and about without the need for finger pricks.†
Discover how the Libre Ecosystem of products and apps connect together to help you manage your diabetes better.
Use our cloud-based management solution LibreView₼ as an option to stay connected to your healthcare team.
Find answers to some of the most common questions about LibreLinkUp app§ and the rest of the FreeStyle Libre Portfolio.
Images are for illustrative purposes only. Not real patient or data.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
^ Notifications will only be received when alarms are turned on and the sensor is within 6 meters of the reading device. You must have override do not disturb settings enabled to receive alarms and alerts on your smartphone.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Sharing of glucose data requires registration with LibreView.
ǁ The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
Ѱ For children aged 4-12 using the FreeStyle Libre 2 or for children aged 2-12 using the FreeStyle Libre 2 plus sensor, a caregiver at least 18 years old is responsible for supervising, managing, and assisting them in using the FreeStyle Libre 2 system and interpreting its readings.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
1. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142.
2. Data on file, Abbott Diabetes Care, Inc.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.